Medical Product Q1 Earnings Due On May 9: XRAY, HSIC & More
Zacks Investment Research | May 07, 2017 09:19PM ET
It is so far so good for the first-quarter reporting cycle, which is in its tail end with financial results from 412 members in the S&P 500 cohort. For Medical, one of the 16 broader Zacks sectors, we have results from 88.6% of the total market cap. Per the latest Can DENTSPLY Pull a Surprise this Earnings Season? )
DENTSPLY SIRONA Inc. Price and EPS Surprise
Will Henry Schein Deliver a Surprise in Q1 Earnings? )
Henry Schein, Inc. Price and EPS Surprise
Can Penumbra Spring a Surprise this Earnings Season? )
Steris Plc (NYSE:STE) : Headquartered in Ohio, Steris develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. The company was originally known as STERIS Corporation.
Our proven model does not conclusively show an earnings beat for the company. Steris currently has a Zacks Rank #4 (Sell) and an Earnings ESP of 0.94%. We caution against stocks with a Zacks Rank #4 or 5 (Strong Sell) going into the earnings announcement.
Inogen Inc. (NASDAQ:INGN) is a provider of innovative respiratory products for use in the homecare setting. Inogen’s unique direct-to-customer business model, innovative product portfolio and growing patient base are currently drawing investor attention.
Our proven model does not conclusively show an earnings beat for Inogen which currently has a Zacks Rank #3 and an Earnings ESP of 0.00%. This is because both the Most Accurate estimate and the Zacks Consensus Estimate stand at 12 cents.
Inogen, Inc Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.